BRAIN Biotech AG (BNN) — Long-term Investment Intensity
BRAIN Biotech AG (BNN) has a Long-term Investment Intensity of 2.2% as of September 2019. Long-term investments of €1.44 Million represent 2.2% of total assets of €66.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BNN net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BRAIN Biotech AG Long-term Investment Intensity (2014–2019)
This chart shows how BRAIN Biotech AG's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 2.2%, reflecting long-term investments of €1.44 Million against total assets of €66.12 Million EUR. Also explore BRAIN Biotech AG assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for BRAIN Biotech AG (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for BRAIN Biotech AG from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is BRAIN Biotech AG worth.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.2% | €1.44 Million | €66.12 Million | ▼ -0.5 pp |
| 2018 | 2.7% | €1.98 Million | €74.46 Million | ▲ +2.4 pp |
| 2017 | 0.2% | €166.00K | €68.50 Million | ▼ -0.1 pp |
| 2016 | 0.4% | €168.00K | €47.51 Million | ▲ +0.4 pp |
| 2015 | 0.0% | €2.00 | €30.41 Million | ▼ -0.6 pp |
| 2014 | 0.6% | €158.64K | €25.07 Million | — |